Adam Scott
Adam Scott
 |RSS

Adam B. Scott is a co-founder of Argyle Capital Partners. A veteran of Morgan Stanley and UBS Wealth Management in Beverly Hills, Adam uses his extensive market knowledge and macro-level analysis to implement customized solutions for high net worth private clients.

Scott is a graduate of Tufts University in Boston where he studied mechanical engineering and finance.

3 Attractive Ways to Play This Interest-Rate-Sensitive Environment

By

Adam Scott

| Mar 06, 2018 | 2:30 PM EST
What I like about buying these interest-rate-sensitive securities here is that there's a pretty decent margin of safety.

Low VIX Doesn't Mean High Gains

By

Adam Scott

| May 10, 2017 | 3:00 PM EDT
There are better indicators for the broader markets, and they're flashing red.

This Euphoria Looks Very Much Like Old-Fashioned Complacency

By

Adam Scott

| Feb 13, 2017 | 11:00 AM EST
Just think about what the market has shrugged off in the past nine months.

Are the Financial Media on Your Side?

By

Adam Scott

| Nov 30, 2016 | 9:00 AM EST
In many ways, what you hear is no more than a sales pitch.

6 Months Later, It's a Whole New Ballgame

By

Adam Scott

| Aug 16, 2016 | 9:00 AM EDT
Not too long ago, it was best to stay from foreign assets and energy exposure. That was then, this is now.

What 6 Data Points Tell Us About the Market Real Money Pro($)

By

Adam Scott

| May 16, 2016 | 12:00 PM EDT
What's changed in the last 3 months?

What If Things Are Actually OK?

By

Adam Scott

| Mar 02, 2016 | 7:30 AM EST
It's amazing how many investors are positioned for the worst; here are reasons to rethink that approach.

'The War of 1,812' May Finally Be Over

By

Adam Scott

| Feb 16, 2016 | 2:00 PM EST
Action on 6 battlefronts show reasons for optimism.

'The War of 1,812' May Finally Be Over Real Money Pro($)

By

Adam Scott

| Feb 16, 2016 | 9:49 AM EST
Action from 6 battlefronts show reasons for optimism.

To Make Money, Stop Worrying About the Bear Market and Be Patient

By

Adam Scott

| Jan 26, 2016 | 8:00 AM EST
It is at times like this that opportunities occur.

Columnist Conversations

Kevin Curran:
Shorts Might Need Some Medicine
Tilray's staggering 41% rise this morning leaves the company with an insane valuation and leaves Canopy Growth...
Brian Sozzi:
Cannabis Craziness
I badly want to be the person that calls the top in red-hot cannabis stocks, but fear looking like a short-ter...
Brian Sozzi:
On Tesla....
Now the government will get to really dive into the inner workings of Tesla (TSLA) . Who knows what else they...
Carolyn Boroden:
GS Daily
In GS I see key price support at the 224.49-226.42 area.  I also have timing for a possible low.  I ...
See all »

BEST IDEAS

SEE MORE»

News Breaks

Powered by
See More ยป

COLUMNIST TWEETS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.
Compare Brokers